EMDR and quality of life after an Alzheimer's diagnosis: A Single-Case Experimental Design Study

This study employs a multiple baseline design with an ABA structure to investigate the feasibility and potential impact of Eye Movement Desensitization and Reprocessing (EMDR) therapy in individuals who have recently (between two months and one year) received a diagnosis of Alzheimer’s dementia. The study includes: 1. A-baseline phase: multiple weekly baseline measurements (the baseline duration consists of 3, 4 or 5 weeks) across participants. 2. B-intervention phase: seven individual EMDR sessions delivered once a week for seven consecutive weeks by a trained EMDR therapist. Each session lasts 60 minutes (except session 1: 90minutes). 3. A-follow-up phase: eight weekly follow-up measurements. The outcome domains investigated in the study are emotional functioning, cognitive functioning and quality of life. The repeated measures allow examination of within-participant changes over time.